FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs
Hematopoietic Stem Cells (HSCs) are a unique population of cells, capable of reconstituting the blood system of an organism through orchestrated self-renewal and differentiation. They play a pivotal role in stem cell therapies, both autologous and allogeneic. In the field of gene and cell therapy, H...
Main Authors: | Emmanouil Simantirakis, Ioannis Tsironis, George Vassilopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/3/332 |
Similar Items
-
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
by: Parin Rattananon, et al.
Published: (2021-10-01) -
Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
by: Arun K. Nalla, et al.
Published: (2016-03-01) -
Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy
by: Sarah M. Larson, et al.
Published: (2017-05-01) -
Large Animal Models for Foamy Virus Vector Gene Therapy
by: Peter A. Horn, et al.
Published: (2012-12-01) -
Dlk1 maintains adult mice long-term HSCs by activating Notch signaling to restrict mitochondrial metabolism
by: Deyu Huang, et al.
Published: (2023-01-01)